Drug Price Trends for NDC 51862-0188

Average Pharmacy Cost for 51862-0188

Drug Name	NDC	Price/Unit ($)	Unit	Date
MORPHINE SULF ER 100 MG TABLET	51862-0188-01	0.99810	EACH	2024-10-23
MORPHINE SULF ER 100 MG TABLET	51862-0188-01	0.94858	EACH	2024-09-18
MORPHINE SULF ER 100 MG TABLET	51862-0188-01	0.95446	EACH	2024-08-21
MORPHINE SULF ER 100 MG TABLET	51862-0188-01	0.90007	EACH	2024-07-17
MORPHINE SULF ER 100 MG TABLET	51862-0188-01	0.95449	EACH	2024-06-19
MORPHINE SULF ER 100 MG TABLET	51862-0188-01	0.92392	EACH	2024-05-22

Best Wholesale Price for NDC 51862-0188

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
MORPHINE SO4 100MG TAB,SA	Golden State Medical Supply, Inc.	51862-0188-01	100	175.75	1.75750	2023-06-15 - 2028-06-14	FSS

Market Analysis and Price Projections for NDC 51862-0188: Morphine Sulfate

The pharmaceutical industry is constantly evolving, with drug prices and market trends playing a crucial role in shaping healthcare accessibility and affordability. In this comprehensive analysis, we'll dive deep into the market dynamics and price projections for the drug identified by National Drug Code (NDC) 51862-0188, which corresponds to Morphine Sulfate manufactured by Mayne Pharma.

Understanding NDC 51862-0188

NDC 51862-0188 represents Morphine Sulfate, a powerful opioid analgesic used for pain management. Manufactured by Mayne Pharma, this drug plays a significant role in the pain management sector of the pharmaceutical market[5].

Product Details

• Drug Name: Morphine Sulfate
• Manufacturer: Mayne Pharma Commercial LLC
• NDC: 51862-0188
• Drug Class: Opioid Analgesic

Current Market Status

As of the latest available data, Morphine Sulfate (NDC 51862-0188) is actively marketed in the United States. The drug's market presence is notable, given the ongoing opioid crisis and the scrutiny surrounding pain management medications[5].

Pricing Trends

While specific pricing data for NDC 51862-0188 is not directly available in the provided search results, we can infer general trends based on industry-wide data:

Vizient, Inc. released its summer Pharmacy Market Outlook estimating the 2025 overall drug price inflation rate for pharmaceuticals at 3.81%[2].

This projection suggests that Morphine Sulfate, like many other pharmaceuticals, may experience moderate price increases in the coming year.

Factors Influencing Price Projections

Several factors are likely to influence the price projections for Morphine Sulfate (NDC 51862-0188) in the coming years:

1. Overall Drug Price Inflation

The projected 3.81% inflation rate for pharmaceuticals in 2025 provides a baseline for potential price changes[2]. This rate reflects broader economic trends and industry-specific factors.

2. Opioid Market Dynamics

Given the ongoing opioid crisis, regulations and market pressures specific to opioid medications may impact pricing strategies for Morphine Sulfate.

3. Manufacturing Costs

Changes in production costs, including raw materials and labor, can influence the final price of the drug.

4. Competition

The presence of generic alternatives or new pain management solutions could exert downward pressure on prices.

5. Regulatory Environment

Any new regulations or policy changes related to opioid medications could significantly impact pricing and market availability.

Industry Trends Affecting NDC 51862-0188

The pharmaceutical industry is undergoing significant transformations that could impact the market for Morphine Sulfate:

1. Shift Towards Alternative Pain Management

There's a growing emphasis on non-opioid pain management solutions, which could affect the demand for traditional opioids like Morphine Sulfate.

2. Technological Advancements

More than 85% of biopharma executives we surveyed say they are investing in data, AI and digital tools in 2025 to build supply chain resiliency[7].

These investments could lead to more efficient production and distribution, potentially impacting pricing.

3. Focus on High Unmet Needs

Pharmaceutical companies are increasingly shifting focus to therapy areas with high unmet needs[7]. While pain management remains crucial, this trend could influence resource allocation and pricing strategies for established drugs like Morphine Sulfate.

Price Projection Scenarios for NDC 51862-0188

Based on the available data and industry trends, we can project several scenarios for the pricing of Morphine Sulfate (NDC 51862-0188) in the near future:

1. Baseline Scenario

Assuming the drug follows the projected overall inflation rate of 3.81%, we might see a moderate increase in price by 2025[2].

2. Regulatory Pressure Scenario

Increased scrutiny on opioid medications could lead to price stabilization or even slight decreases to maintain market access.

3. Supply Chain Optimization Scenario

If Mayne Pharma successfully implements AI and digital tools to optimize their supply chain, as many companies are doing, it could potentially lead to cost savings that might be passed on to consumers[7].

Market Positioning of Mayne Pharma

Mayne Pharma, the manufacturer of NDC 51862-0188, plays a significant role in the pharmaceutical landscape:

1. Product Portfolio

Mayne Pharma produces a variety of medications, including several formulations of Morphine Sulfate[5]. This diversification could influence their pricing strategy for individual products.

2. Market Presence

As a established player in the generic drug market, Mayne Pharma's pricing decisions for Morphine Sulfate are likely influenced by their overall market positioning and competition from other manufacturers.

Comparative Analysis with Similar Drugs

To better understand the market position of NDC 51862-0188, it's helpful to compare it with similar pain management drugs:

1. Other Morphine Formulations

Mayne Pharma produces multiple Morphine Sulfate products, each with its own NDC. Comparing the pricing trends across these formulations could provide insights into the company's overall strategy for this drug class[5].

2. Alternative Opioids

Comparing the price trends of Morphine Sulfate with other opioid pain medications could reveal broader market patterns affecting this drug category.

3. Non-Opioid Alternatives

As the healthcare industry seeks alternatives to opioids for pain management, tracking the pricing of non-opioid pain medications could indicate potential competitive pressures on Morphine Sulfate.

Regulatory Landscape and Its Impact on Pricing

The regulatory environment plays a crucial role in shaping the market for opioid medications like Morphine Sulfate:

1. Opioid-Specific Regulations

Any new regulations targeting opioid prescriptions or distribution could significantly impact the demand and pricing for Morphine Sulfate.

2. General Pharmaceutical Pricing Policies

Broader policies aimed at controlling drug prices could affect the pricing strategy for NDC 51862-0188.

3. International Price Comparisons

In 2022, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as in the rest of the world[4].

This significant price disparity could lead to increased scrutiny and potential policy interventions that might affect domestic pricing strategies.

Supply Chain Considerations

The efficiency and resilience of the supply chain can significantly impact drug pricing and availability:

1. Raw Material Sourcing

Any changes in the availability or cost of raw materials for Morphine Sulfate production could influence its final price.

2. Manufacturing Efficiency

Improvements in manufacturing processes, potentially through the use of AI and digital tools, could lead to cost savings[7].

3. Distribution Networks

Optimizing distribution channels could reduce costs and potentially impact the final price of the drug.

Future Market Outlook for NDC 51862-0188

Looking ahead, several factors will shape the market for Morphine Sulfate (NDC 51862-0188):

1. Evolving Pain Management Practices

As healthcare providers seek to balance effective pain management with concerns about opioid addiction, the role of Morphine Sulfate in treatment protocols may evolve.

2. Technological Advancements

Continued investments in data, AI, and digital tools by pharmaceutical companies could lead to more efficient production and distribution, potentially affecting pricing[7].

3. Policy Changes

Any significant changes in healthcare policy, particularly those targeting drug pricing or opioid use, could have a substantial impact on the market for Morphine Sulfate.

Key Takeaways

• NDC 51862-0188 represents Morphine Sulfate, an important opioid analgesic manufactured by Mayne Pharma.
• The overall drug price inflation rate for 2025 is projected at 3.81%, which could serve as a baseline for price changes in Morphine Sulfate.
• Factors influencing price projections include overall drug inflation, opioid market dynamics, manufacturing costs, competition, and the regulatory environment.
• Industry trends such as the shift towards alternative pain management and technological advancements in supply chain management could impact the market for Morphine Sulfate.
• The regulatory landscape, particularly concerning opioid medications, plays a crucial role in shaping the market and pricing strategies.
• Future market outlook will depend on evolving pain management practices, technological advancements, and potential policy changes.

FAQs

1. Q: How often do pharmaceutical companies typically adjust their drug prices? A: Many pharmaceutical companies adjust their prices annually, with the largest number of price increases occurring in January and July each year.

2. Q: Are there any generic alternatives to Morphine Sulfate (NDC 51862-0188)? A: Yes, there are generic versions of Morphine Sulfate available from various manufacturers. However, the specific formulation and strength may vary.

3. Q: How might the ongoing opioid crisis affect the pricing of Morphine Sulfate? A: The opioid crisis has led to increased scrutiny and regulation of opioid medications, which could potentially lead to more conservative pricing strategies or even price decreases to maintain market access.

4. Q: What role does the FDA play in drug pricing? A: While the FDA doesn't directly control drug prices, its policies on drug approval, including for generic alternatives, can indirectly influence pricing by affecting market competition.

5. Q: How might advancements in pain management technology impact the market for Morphine Sulfate? A: New pain management technologies or non-opioid alternatives could potentially reduce demand for traditional opioids like Morphine Sulfate, which could impact its pricing and market position.

Sources cited: [2] https://www.vizientinc.com/newsroom/news-releases/2024/vizient-projects-drug-price-inflation [4] https://www.drugpatentwatch.com/p/drug-price/ndc/67457-0212 [5] https://www.findacode.com/ndc/labelers/Mayne_Pharma--51862 [7] https://www.zs.com/insights/pharmaceutical-trends-2025-outlook-ai-supplychain-and-beyond